Crinetics Pharmaceuticals, Inc. (CRNX)
Crinetics Pharmaceuticals, Inc. (CRNX) has a 32-report earnings history dating back to Aug 30, 2018. Its average absolute post-earnings move is ±4.75%, and 46.9% of those reactions were positive. Its largest post-earnings gain was +15.53% (Mar 30, 2022) and its largest decline was -13.94% (May 07, 2026). The next earnings report is predicted for 2026-08-07 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
32
Avg Abs. Movement
±4.75%
Positive %
46.9%
Negative %
53.1%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 07, 2026 | ☽ POST | $41.94 | $43.62 | $43.48 | 149,572 | -13.94% | open_in_new |
| Feb 26, 2026 | ☽ POST | $43.10 | $43.84 | $43.74 | 824,700 | -6.04% | open_in_new |
| Nov 06, 2025 | ☽ POST | $42.72 | $43.89 | $43.49 | 2,108,800 | -8.02% | open_in_new |
| Aug 07, 2025 | ☽ POST | $28.75 | $28.96 | $27.88 | 1,067,300 | -3.69% | open_in_new |
| May 08, 2025 | ☽ POST | $31.19 | $33.26 | $32.70 | 1,212,600 | -6.18% | open_in_new |
| Feb 27, 2025 | ☽ POST | $32.80 | $33.97 | $33.21 | 977,900 | +7.74% | open_in_new |
| Nov 12, 2024 | ☽ POST | $59.99 | $60.48 | $58.78 | 935,100 | +0.24% | open_in_new |
| Aug 08, 2024 | ☽ POST | $49.15 | $50.84 | $50.74 | 483,000 | -6.11% | open_in_new |
| May 09, 2024 | ☽ POST | $51.00 | $51.00 | $49.42 | 841,300 | -2.87% | open_in_new |
| Feb 28, 2024 | ☽ POST | $46.65 | $47.48 | $42.76 | 1,856,800 | -4.26% | open_in_new |
| Nov 07, 2023 | ☽ POST | $30.22 | $30.23 | $29.52 | 1,083,400 | -3.62% | open_in_new |
| Aug 08, 2023 | ☀ PRE | $17.51 | $17.66 | $17.30 | 569,100 | -3.89% | open_in_new |
| May 04, 2023 | ☽ POST | $21.66 | $22.09 | $21.37 | 434,000 | +4.59% | open_in_new |
| Feb 28, 2023 | ☽ POST | $19.27 | $19.75 | $19.64 | 565,500 | +0% | open_in_new |
| Nov 14, 2022 | ☀ PRE | $18.16 | $18.98 | $18.43 | 288,500 | +0.22% | open_in_new |
| Aug 12, 2022 | ☀ PRE | $20.28 | $20.84 | $20.55 | 715,000 | -0.19% | open_in_new |
| May 12, 2022 | ☽ POST | $16.60 | $17.91 | $17.71 | 307,800 | +5.87% | open_in_new |
| Mar 30, 2022 | ☽ POST | $19.27 | $19.61 | $19.00 | 257,500 | +15.53% | open_in_new |
| Nov 05, 2021 | ☀ PRE | $28.45 | $28.45 | $27.90 | 241,100 | +1.01% | open_in_new |
| Aug 10, 2021 | ☽ POST | $16.87 | $17.86 | $17.60 | 360,900 | +8.64% | open_in_new |
| May 06, 2021 | ☽ POST | $17.17 | $17.26 | $16.65 | 85,600 | +1.86% | open_in_new |
| Mar 30, 2021 | ☽ POST | $15.15 | $15.63 | $15.44 | 100,600 | -1.04% | open_in_new |
| Nov 06, 2020 | ☀ PRE | $13.56 | $13.56 | $12.66 | 174,000 | -6.01% | open_in_new |
| Aug 07, 2020 | ☀ PRE | $14.77 | $16.80 | $16.14 | 190,400 | +8.83% | open_in_new |
| May 08, 2020 | ☀ PRE | $17.18 | $18.34 | $17.82 | 57,100 | +5.01% | open_in_new |
| Mar 09, 2020 | ☽ POST | $18.81 | $19.91 | $18.96 | 38,200 | -10.07% | open_in_new |
| Nov 12, 2019 | ☽ POST | $19.16 | $19.92 | $18.91 | 21,600 | +1.43% | open_in_new |
| Aug 13, 2019 | ☽ POST | $18.70 | $19.89 | $19.40 | 41,400 | -7.22% | open_in_new |
| May 13, 2019 | ☽ POST | $25.53 | $25.90 | $25.07 | 49,700 | +1.28% | open_in_new |
| Mar 13, 2019 | ☽ POST | $23.60 | $24.60 | $24.53 | 81,000 | +3.63% | open_in_new |
| Nov 13, 2018 | ☽ POST | $26.57 | $30.00 | $29.31 | 31,100 | -1.88% | open_in_new |
| Aug 30, 2018 | ☽ POST | $30.46 | $35.04 | $30.32 | 199,500 | -1.09% | open_in_new |
Earnings Count
32
Total earnings in dataset
Avg Abs. Movement
±4.75%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260602 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| 10-Q | 20260507 | open_in_new SEC.gov |
| 8-K | 20260507 | open_in_new SEC.gov |
| 144 | 20260504 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260429 | open_in_new SEC.gov |
| ARS | 20260429 | open_in_new SEC.gov |
| DEFA14A | 20260429 | open_in_new SEC.gov |
Frequently asked about CRNX earnings
When does Crinetics Pharmaceuticals, Inc. report earnings next? expand_more
Crinetics Pharmaceuticals, Inc. (CRNX)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does CRNX stock move after earnings? expand_more
Over 32 reports, CRNX has moved an average of ±4.75% the session after earnings, closing higher 46.9% of the time.
What was CRNX's biggest post-earnings move? expand_more
CRNX's largest post-earnings gain on record was +15.53% on Mar 30, 2022, and its largest decline was -13.94% on May 07, 2026.
Where can I find Crinetics Pharmaceuticals, Inc.'s SEC filings? expand_more
All of Crinetics Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right